Latest News
Selpercatinib Induces Durable and Sustained Responses in Patients With MTC
Radiolabeled Somatostatin Analogs May Be Useful in Managing Recurrent MTC
New Study to Investigate 18F-PSMA Positron Emission Tomography for MTC
New Tyrosine Kinase Inhibitors May Provide Therapeutic Benefit for MTC
Ultrasonographic Features May Aid in Diagnosing Cervical Lymph Node Metastases From MTC
Researchers Report Another Case of Serum Calcitonin-Negative MTC
Alternatives to TNM May Be Superior for Predicting Survival in MTC
MTC Tumor Grade Predicts Calcitonin Doubling Time and Recurrence
Novel Tension-Free Thyroidectomy Technique Improves Surgical Outcomes
Latest Clinical Trials
Insights
Tailoring Thyroid Cancer Treatment for Pregnant Women
During the early stages of most clinical trials, medical researchers tend to recruit healthy adult males with no comorbidities. This is because they generally represent the safest segment of the population for experimental therapies to be tested on. In contrast, women of reproductive age tend to be the last segment of the population to be…
The Different Paths to a Diagnosis of MTC
There are various options for physicians to diagnose MTC, from physical examination to an ultrasound scan to molecular imaging.
Calcitonin: From Multipurpose Drug to Biomarker for MTC
Previous to its widespread use as a cancer biomarker, including its role in raising suspicion of medullary thyroid cancer (MTC), calcitonin had an interesting history. In the Journal of Musculoskeletal Neuronal Interactions, Srinivasan and colleagues detailed the early history of calcitonin. It was first discovered as a blood-calcium lowering hormone in 1961. It has been…
Patient Perspectives
How to Prepare for Medullary Thyroid Cancer Treatment
I am grateful that medullary thyroid cancer (MTC) does not include typical chemotherapy options like other cancers.
Dos and Don’ts for HCPs When Treating a Cancer Patient
For HCPs, I think it might be helpful to point out both the dos and the don’ts from the perspective of someone living with medullary thyroid carcinoma (MTC).
When Living With MTC, Hearing You’re Stable Is Good News
I deal with the persistent side effects of medullary thyroid cancer (MTC) as well as the treatments I received for it.
MTC Features
The Alliance for Regenerative Medicine Fights for Better Cell, Gene Therapies
The Alliance for Regenerative Medicine aims to help in the development of safe and effective regenerative therapies that can benefit rare disease patients.
‘Fundamental Flaws’ Plague Drug Development Process, Ultragenyx CEO Dr. Emil Kakkis Says
Ultragenyx CEO Dr. Emil D. Kakkis said federal regulators should focus more on biomarkers and less on clinical endpoints when it comes to drug approvals.
Thyroid Expert Outlines Best Options for MTC Diagnosis, Surgery
Dr. Haggi Mazeh, chief of surgery at one of Israel’s top hospitals, discusses diagnosing and treating medullary thyroid carcinoma.
Management of Medullary Thyroid Carcinoma Possible, if Caught in Time
MTC “can get aggressive and nasty” but it is not necessarily a death sentence, said surgical oncologist David Goldenberg, MD, FACS, author of a new book.
Rare Care Podcast
Endocrine Surgeon Dr. Haggi Mazeh Describes the Challenges of Treating MTC
- Loading...
Loading...
Loading... 
Loading...